UPDATE: BMO Capital Markets Raises PT on Tenet Healthcare Corporation on 4Q12 Earnings Results
Posted on February 27, 2013 at 09:42 AM EST
In a report published Wednesday, BMO Capital Markets reiterated its reiterated its Market Perform rating on Tenet Healthcare Corporation (NYSE: THC ), and raised its price target from $38.00 to $40.00. BMO Capital Markets noted, “Producing EBITDA growth and modest volume increases, Tenet continues to execute well enough to please